Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
COVID-19
Sort By
Newest First
1 / 13
Pandemic
Global Health at a Crossroads and the Future of Pandemic Preparedness
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-17
Mar 12, 2025
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
Suranjana Sen, Ph.D.
Sino Biological
PAO-01-24-CL-4
Jan 24, 2024
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07
Nov 09, 2023
Recombinant Proteins
The Expanding Role for Recombinant Proteins in Research
Rob Burgess, Ph.D.
Sino Biological
PAO-11-22-PATV-01
Jan 06, 2023
Mental Health
Mental Health During a Global Pandemic
Marc Technow
Nice Insight
PAO-06-022--NI-03
Jun 24, 2022
COVID-19 Breathalyzer Diagnostic
Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
U.S. Food & Drug Administration
PR-M04-22-09
Apr 14, 2022
COVID-19 Vaccines
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-05
Mar 18, 2022
Remote Auditing
Will Remote Pharma GMP Auditing Continue Post-COVID?
Alasdair Leckie
PAO-02-022-CL-21
Mar 16, 2022
Antibody Therapeutics
Developing New Antibody Therapeutics for COVID-19 and Beyond
Ian Chan
Abpro
PAO-01-22-CL-01
Mar 12, 2022
COVID-19 Vaccines
The Global Immunization Disparity
Komal Hatti
IPS-Integrated Project Services, LLC
PAO-02-022-CL-04
Mar 12, 2022
COVID-19 Prevention
AstraZeneca to Supply Canada with 100,000 Doses of Evusheld, a Long-Acting Antibody Combination for the Prevention of COVID-19
AstraZeneca Canada
PR-M02-22-21
Feb 23, 2022
COVID-19 Antiviral
Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
Model Medicines
PR-M02-22-05
Feb 08, 2022
COVID-19 Vaccine
FDA Approves SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine
Brand Institute
PR-M02-22-01
Feb 01, 2022
COVID-19 Research
MU Study Identifies Mutations Specific to Omicron Variant
University of Missouri
PR-M01-22-17
Jan 25, 2022
Data Connectivity
Discussing the Advancements in Oncology
Tim Roberts
PCI Pharma Services
PATV-12-21-01
Jan 19, 2022
Immunotherapy
Immune Biosolutions Reports That Its Lead Immunotherapy Product IBIO123 Neutralizes 100% of the SARS-CoV-2 Variants of Concern (VOCs), Including Omicron
Immune Biosolutions
PR-M01-22-06
Jan 10, 2022
Thermal Packaging
With Omicron Variant on the Rise, Thermal Custom Packaging (TCP) is Providing Secure Transportation of COVID Vaccine
Thermal Custom Packaging
PR-M01-22-02
Jan 04, 2022
Cell Therapy
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis
Ashish Patel, Ph.D.
The National Institute for Health Research (NIHR) Guy’s and St Thomas’ Biomedical Research Centre (BRC)
PAO-09-21-CL-13
Sep 29, 2021
COVID19 Nasal Spray
pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic Nasal Spray Prevents Infection from SARS-CoV-2
pHOXBIO
PR-M09-21-07
Sep 24, 2021
COVID-19 Nasal Spray
ENA Respiratory Begins Phase I Study of COVID-19 Preventative Nasal Spray Designed to Stimulate Body’s Firstline Immune Defense in the Nose
Ena Respiratory
PR-M07-21-05
Jul 14, 2021
1 / 13
